# clm_2B61F63D78FE

subject: AbbVie (/record/abbvie.md)  
predicate: cash_and_equivalents  
value: 6,569,000,000 United States dollar  
valid_from: 2026-06-30  
valid_to: 2026-09-30  
published: 2026-08-03  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_A17F69D94691  
last_updated: 2026-11-08  
cite: AsOf. "AbbVie cash and equivalents: 6,569,000,000 United States dollar", as of 2026-06-30 (until 2026-09-30). Claim clm_2B61F63D78FE, https://asof.is/claim/clm_2B61F63D78FE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000026/0001551152-26-000026-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2026, filed 2026-08-03  

## Sources

- https://www.sec.gov/Archives/edgar/data/1551152/000155115226000026/0001551152-26-000026-index.htm (primary, SEC EDGAR 10-Q Q2 FY2026, published 2026-08-03)

## Supersedes

- [AbbVie](/record/abbvie.md) | cash_and_equivalents | 9,391,000,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_2B61F63D78FE](/claim/clm_2B61F63D78FE.md) | [clm_E7E1876E4E88](/claim/clm_E7E1876E4E88.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.